Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1401)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
31
Price
$583.56
Total Value
$18.09K
Shares Held After
44,240
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
602
Price
$582.75
Total Value
$350.82K
Shares Held After
44,271
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
610
Price
$581.72
Total Value
$354.85K
Shares Held After
44,873
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
190
Price
$580.54
Total Value
$110.30K
Shares Held After
45,483
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$579.35
Total Value
$162.22K
Shares Held After
45,673
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$578.56
Total Value
$138.86K
Shares Held After
45,953
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$577.13
Total Value
$207.77K
Shares Held After
46,193
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
399
Price
$576.02
Total Value
$229.83K
Shares Held After
46,553
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
481
Price
$574.87
Total Value
$276.51K
Shares Held After
46,952
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
310
Price
$573.92
Total Value
$177.92K
Shares Held After
47,433
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
931
Price
$572.81
Total Value
$533.28K
Shares Held After
47,743
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
801
Price
$571.58
Total Value
$457.84K
Shares Held After
48,674
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
538
Price
$570.87
Total Value
$307.13K
Shares Held After
49,475
% of Holdings
1.1%
FENNEC PHARMACEUTICALS INC. (FENC)
Raykov Rosty — Director
Shares
10,946
Price
$6.31
Total Value
$69.07K
Shares Held After
113,856
% of Holdings
8.8%
Protara Therapeutics, Inc. (TARA)
Zummo Jacqueline — Chief R&D Officer
Shares
22,598
Price
$5.26
Total Value
$118.87K
Shares Held After
95,961
% of Holdings
19.1%
RESMED INC (RMD)
FARRELL PETER C — Director
Shares
2,000
Price
$225.00
Total Value
$450.00K
Shares Held After
60,773
% of Holdings
3.2%
Edgewise Therapeutics, Inc. (EWTX)
Donovan Joanne M. — CMO
Shares
28,662
Price
$32.31
Total Value
$926.10K
Shares Held After
9,597
% of Holdings
74.9%
Vir Biotechnology, Inc. (VIR)
SATO VICKI L — Director
Shares
22,000
Price
$9.07
Total Value
$199.62K
Shares Held After
1,100,391
% of Holdings
2.0%
Tivic Health Systems, Inc. (TIVC)
Valauri Christina Rizopoulos — Director
Shares
19,000
Price
$0.95
Total Value
$18.01K
Shares Held After
19,000
% of Holdings
100.0%
CAPRICOR THERAPEUTICS, INC. (CAPR)
Sabar Karimah Es — Director
Shares
53,735
Price
$31.03
Total Value
$1.67M
Shares Held After
0
% of Holdings
100.0%
Alkermes plc. (ALKS)
Hopkinson Craig C. — EVP R&D, Chief Medical Officer
Shares
9,000
Price
$35.51
Total Value
$319.60K
Shares Held After
85,389
% of Holdings
9.5%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
1,100
Price
$86.05
Total Value
$94.66K
Shares Held After
61,202
% of Holdings
1.8%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
13,540
Price
$85.41
Total Value
$1.16M
Shares Held After
62,302
% of Holdings
17.9%
Kymera Therapeutics, Inc. (KYMR)
Ridloff Elena — Director
Shares
1,200
Price
$86.05
Total Value
$103.26K
Shares Held After
0
% of Holdings
100.0%
Kymera Therapeutics, Inc. (KYMR)
Ridloff Elena — Director
Shares
3,400
Price
$85.19
Total Value
$289.66K
Shares Held After
1,200
% of Holdings
73.9%
Alignment Healthcare, Inc. (ALHC)
JOYCE CHRISTOPHER J — Chief Legal and Admin. Officer
Shares
18,013
Price
$17.79
Total Value
$320.49K
Shares Held After
305,451
% of Holdings
5.6%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
4,278
Price
$4.97
Total Value
$21.26K
Shares Held After
426,816
% of Holdings
1.0%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
7,500
Price
$66.63
Total Value
$499.72K
Shares Held After
422,830
% of Holdings
1.7%
Altimmune, Inc. (ALT)
Durso Jerome Benedict — Director
Shares
15,000
Price
$3.14
Total Value
$47.10K
Shares Held After
47,500
% of Holdings
31.6%
Altimmune, Inc. (ALT)
WEAVER GREGORY L — Chief Financial Officer
Shares
10,000
Price
$3.15
Total Value
$31.50K
Shares Held After
38,078
% of Holdings
26.3%
ADC Therapeutics SA (ADCT)
Redmile Group, LLC — 10% Owner
Shares
188,407
Price
$3.75
Total Value
$706.90K
Shares Held After
12,957,305
% of Holdings
1.4%
ADC Therapeutics SA (ADCT)
Redmile Group, LLC — 10% Owner
Shares
196,229
Price
$3.75
Total Value
$736.25K
Shares Held After
15,470,502
% of Holdings
1.3%
Canopy Growth Corp (CGC)
Lazzarato David Angelo — Director
Shares
15,624
Price
$0.93
Total Value
$14.53K
Shares Held After
72,048
% of Holdings
17.8%
Canopy Growth Corp (CGC)
ATKINS M SHAN — Director
Shares
2,074
Price
$0.93
Total Value
$1.93K
Shares Held After
41,390
% of Holdings
4.8%
Canopy Growth Corp (CGC)
Yanofsky Theresa — Director
Shares
10,373
Price
$0.93
Total Value
$9.65K
Shares Held After
53,145
% of Holdings
16.3%
Canopy Growth Corp (CGC)
BAYERN JOSEPH — Director
Shares
2,658
Price
$0.93
Total Value
$2.47K
Shares Held After
40,000
% of Holdings
6.2%
Vivos Therapeutics, Inc. (VVOS)
Skaff Michael C — 10% Owner
Shares
308,848
Price
$1.34
Total Value
$413.86K
Shares Held After
1,353,625
% of Holdings
22.8%
Vivos Therapeutics, Inc. (VVOS)
Skaff Michael C — 10% Owner
Shares
1,044,777
Price
$1.34
Total Value
$1.40M
Shares Held After
1,044,777
% of Holdings
100.0%
Mineralys Therapeutics, Inc. (MLYS)
Karydas Daphne — Director
Shares
3,000
Price
$25.00
Total Value
$75.00K
Shares Held After
6,200
% of Holdings
32.6%
Allogene Therapeutics, Inc. (ALLO)
Beneski Benjamin Machinas — SVP, Chief Technical Officer
Shares
2,867
Price
$2.50
Total Value
$7.17K
Shares Held After
195,338
% of Holdings
1.4%
Mineralys Therapeutics, Inc. (MLYS)
Congleton Jon — Director
Shares
453
Price
$27.05
Total Value
$12.25K
Shares Held After
705,051
% of Holdings
0.1%
Mineralys Therapeutics, Inc. (MLYS)
Congleton Jon — Director
Shares
55,183
Price
$26.54
Total Value
$1.46M
Shares Held After
705,504
% of Holdings
7.3%
Mineralys Therapeutics, Inc. (MLYS)
Congleton Jon — Director
Shares
19,364
Price
$25.50
Total Value
$493.79K
Shares Held After
760,687
% of Holdings
2.5%
Phreesia, Inc. (PHR)
Pale Fire Capital SE — 10% Owner
Shares
1,000,500
Price
$8.16
Total Value
$8.16M
Shares Held After
8,649,329
% of Holdings
11.6%
Processa Pharmaceuticals, Inc. (PCSA)
Neal James R — Director
Shares
789
Price
$2.54
Total Value
$2.00K
Shares Held After
818
% of Holdings
96.5%
Zenas BioPharma, Inc. (ZBIO)
Lu Hongbo — Director
Shares
3,768
Price
$18.63
Total Value
$70.20K
Shares Held After
426,736
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$594.11
Total Value
$118.82K
Shares Held After
40,513
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
700
Price
$593.13
Total Value
$415.19K
Shares Held After
40,713
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
760
Price
$590.36
Total Value
$448.67K
Shares Held After
41,413
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
600
Price
$589.40
Total Value
$353.64K
Shares Held After
42,173
% of Holdings
1.4%
Showing 501–550 of 1401 transactions (page 11 of 29)